New UAE plant to make Covid-19 vaccine from China's Sinopharm | The Business Standard
Skip to main content
  • Home
  • Economy
    • Aviation
    • Banking
    • Bazaar
    • Budget
    • Industry
    • NBR
    • RMG
    • Corporates
  • Stocks
  • Analysis
  • World+Biz
  • Sports
  • Features
    • Book Review
    • Brands
    • Earth
    • Explorer
    • Food
    • Habitat
    • In Focus
    • Luxury
    • Mode
    • Panorama
    • Pursuit
    • Wheels
  • Epaper
    • GOVT. Ad
  • More
    • Subscribe
    • Videos
    • TBS Graduates
    • Thoughts
    • Splash
    • Bangladesh
    • Supplement
    • Infograph
    • Archive
    • COVID-19
    • Long Read
    • Interviews
    • Offbeat
    • Tech
    • Magazine
  • বাংলা
The Business Standard

Tuesday
December 05, 2023

Sign In
Subscribe
  • Home
  • Economy
    • Aviation
    • Banking
    • Bazaar
    • Budget
    • Industry
    • NBR
    • RMG
    • Corporates
  • Stocks
  • Analysis
  • World+Biz
  • Sports
  • Features
    • Book Review
    • Brands
    • Earth
    • Explorer
    • Food
    • Habitat
    • In Focus
    • Luxury
    • Mode
    • Panorama
    • Pursuit
    • Wheels
  • Epaper
    • GOVT. Ad
  • More
    • Subscribe
    • Videos
    • TBS Graduates
    • Thoughts
    • Splash
    • Bangladesh
    • Supplement
    • Infograph
    • Archive
    • COVID-19
    • Long Read
    • Interviews
    • Offbeat
    • Tech
    • Magazine
  • বাংলা
TUESDAY, DECEMBER 05, 2023
New UAE plant to make Covid-19 vaccine from China's Sinopharm

Coronavirus chronicle

29 March, 2021, 12:45 pm
Last modified: 29 March, 2021, 12:50 pm

Related News

  • China's military: US Navy ship 'illegally' entered territorial waters
  • Chinese Embassy donates smart classroom in Sylhet
  • Decoding China: EU, China headed for challenging summit
  • What do we know about China’s respiratory illness surge?
  • US proposes EV Tax credit rules to curb Chinese inputs

New UAE plant to make Covid-19 vaccine from China's Sinopharm

The plant will have a production capacity of 200 million doses a year with three filling lines and five automated packaging lines

29 March, 2021, 12:45 pm
Last modified: 29 March, 2021, 12:50 pm
China's State Councilor and Foreign Minister Wang Yi and UAE's Foreign Minister Abdullah Bin Zayed Al Nahyan show the Chines made Coronavirus (COVID-19) vaccine Sinopharm during their meeting in Abu Dhabi, United Arab Emirates, March 28, 2021. WAM/Handout via REUTERS
China's State Councilor and Foreign Minister Wang Yi and UAE's Foreign Minister Abdullah Bin Zayed Al Nahyan show the Chines made Coronavirus (COVID-19) vaccine Sinopharm during their meeting in Abu Dhabi, United Arab Emirates, March 28, 2021. WAM/Handout via REUTERS

A new factory in Abu Dhabi will start manufacturing a Covid-19 vaccine from Chinese pharmaceutical giant Sinopharm later this year under a joint venture between Sinopharm and Abu Dhabi-based technology company Group 42 (G42).

The project is an expansion of Chinese diplomacy in the Gulf region and helps the United Arab Emirates' quest to diversify its economy away from hydrocarbon production.

The plant, which is being built in the Khalifa Industrial Zone of Abu Dhabi (KIZAD), will have a production capacity of 200 million doses a year with three filling lines and five automated packaging lines, a statement from the joint venture said on Monday.

The Business Standard Google News Keep updated, follow The Business Standard's Google news channel

The vaccine will be called Hayat-Vax when manufactured in the UAE, but is the same inactivated vaccine from the Beijing Institute of Biological Product (BiBP), a unit of Sinopharm's China National Biotec Group (CNBG), that the UAE approved for general use in December.

Production of Hayat-Vax has already begun in the emirate of Ras al-Khaimah under a deal between G42 and Gulf Pharmaceutical Industries PSC, the statement said. That production line has an initial capacity of 2 million doses per month.

The UAE, through G42, hosted Phase III clinical trials of the Sinopharm vaccine from July, which later expanded to other countries in the region including Bahrain. The UAE approved the vaccine for frontline workers in September before making it available to the general public in December.

G42 has previously said it has distribution and manufacturing agreements with Sinopharm and hopes to provide the UAE and other states in the region with the vaccine.

The deal was launched during a two-day visit to the UAE by Chinese Foreign Minister Wang Yi which ended on Sunday.

The joint venture also includes a purpose-built research and development hub for life sciences, biotechnology and vaccine production in KIZAD.

"Our joint venture is also actively looking to bring our capabilities to new markets around the world," G42 CEO Peng Xiao said.

A booth displaying a coronavirus vaccine candidate from China National Biotec Group (CNBG), a unit of state-owned pharmaceutical giant China National Pharmaceutical Group (Sinopharm), is seen at the 2020 China International Fair for Trade in Services (CIFTIS), following the Covid-19 outbreak, in Beijing, China September 4, 2020. REUTERS/Tingshu Wang
A booth displaying a coronavirus vaccine candidate from China National Biotec Group (CNBG), a unit of state-owned pharmaceutical giant China National Pharmaceutical Group (Sinopharm), is seen at the 2020 China International Fair for Trade in Services (CIFTIS), following the Covid-19 outbreak, in Beijing, China September 4, 2020. REUTERS/Tingshu Wang

The UAE has said its trials showed the vaccine has 86% efficacy, while Sinopharm reports 79.34% efficacy based on interim results.

Some people in the UAE failed to develop sufficient antibodies after a second dose of the Sinopharm vaccine and were given a third dose, the UAE health ministry said this month. It said the number was "minimal" compared to the number of vaccines administered.

On Sunday, a Sinopharm executive said the company will need to assess results from overseas Phase III clinical trials to decide whether its two-shot vaccine should be followed by a booster shot.

"Thanks to the close collaboration with the UAE, Sinopharm's vaccine has been now administered to millions of people in the country, the region, and the world," Sinopharm Chairman Liu Jingzhen said at a virtual launch also attended by UAE Foreign Affairs Minister Sheikh Abdullah bin Zayed Al Nahyan.

Top News

Sinopharm Covid-19 Vaccine / Sinopharm / Sinopharm vaccine / Group 42 (G42) / UAE / China / covid-19 vaccine / Coronavirus Vaccine / China National Biotec Group (CNBG) / Khalifa Industrial Zone of Abu Dhabi (KIZAD)

Comments

While most comments will be posted if they are on-topic and not abusive, moderation decisions are subjective. Published comments are readers’ own views and The Business Standard does not endorse any of the readers’ comments.

Top Stories

  • Dollar pressure rises as short-term foreign debt drops $300m in October
    Dollar pressure rises as short-term foreign debt drops $300m in October
  • Record 27% nominations scrapped with  more bigshots rejected
    Record 27% nominations scrapped with  more bigshots rejected
  • File photo of Awami League General Secretary and Road Transport and Bridges Minister Obaidul Quader
    Awami League scraps 10 Dec rally as permission denied

MOST VIEWED

  • LPG cylinders. Photo: Courtesy
    12kg LPG cylinder price up Tk23
  • For the first time, Bangladesh seeks foreign loans to support Rohingyas
    For the first time, Bangladesh seeks foreign loans to support Rohingyas
  • Photo: Collected
    Indonesia volcano erupts, spews ash 3 km into sky
  • External trade through Islamic banks in decline
    External trade through Islamic banks in decline
  • Halal products export receives boost with new policy, but more is required
    Halal products export receives boost with new policy, but more is required
  • Exports up 27% in Nov as peak festival sales begin in West
    Exports up 27% in Nov as peak festival sales begin in West

Related News

  • China's military: US Navy ship 'illegally' entered territorial waters
  • Chinese Embassy donates smart classroom in Sylhet
  • Decoding China: EU, China headed for challenging summit
  • What do we know about China’s respiratory illness surge?
  • US proposes EV Tax credit rules to curb Chinese inputs

Features

A brain drain query: Why do they leave?

A brain drain query: Why do they leave?

1h | Panorama
The school has been flooding since June 2007 and the water level is rising every year. PHOTO: COURTESY

Will Dubai pay heed to the suffering of Sultan Al Nahyan School students in Bangladesh?

1h | Panorama
Masud Ahmad has written one of the finest Bangla novels in recent times, titled ‘Kanchanfuler Kobi,’ centred around the life and works of eminent poet Jibanananda Das. Photo: Rajib Dhar

How little-known Masud Ahmad became the 'Shera Bangali'

1d | Panorama
Designed for utility, the D90 is a giant in comparison to other MG models and misses out on design elements which gives the other models their sporty stance. Photo: Akif Hamid

Maxus D90: Spacious, capable and practical

1d | Wheels

More Videos from TBS

Despite the incentives, remittances are not speeding up

Despite the incentives, remittances are not speeding up

13h | TBS Economy
Terrible Torture in Israeli Prisons: Testimony of Prisoners

Terrible Torture in Israeli Prisons: Testimony of Prisoners

11h | TBS World
Lighterage ship trips halved

Lighterage ship trips halved

13h | TBS Economy
3 commercial ships hit by missiles in Houthi attack in Red Sea

3 commercial ships hit by missiles in Houthi attack in Red Sea

14h | TBS World
EMAIL US
[email protected]
FOLLOW US
WHATSAPP
+880 1847416158
The Business Standard
  • About Us
  • Contact us
  • Sitemap
  • Privacy Policy
  • Comment Policy
Copyright © 2023
The Business Standard All rights reserved
Technical Partner: RSI Lab

Contact Us

The Business Standard

Main Office -4/A, Eskaton Garden, Dhaka- 1000

Phone: +8801847 416158 - 59

Send Opinion articles to - [email protected]

For advertisement- [email protected]